CON: Severity scores are not useful

J. Chalmers (Edinburgh, United Kingdom)

Source: Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Session: Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Session type: Symposium
Number: 141
Disease area: Respiratory infections

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Chalmers (Edinburgh, United Kingdom). CON: Severity scores are not useful. Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PRO: Severity scores are useful
Source: Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Year: 2012


Severity of bronchiectasis: FACED Score vs Bronchiectasis Severity Index
Source: International Congress 2019 – Bronchiectasis
Year: 2019


Bronchiectasis Severity Index and FACED score correlation determinants
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Severity assessment tools in CAP
Source: Eur Respir Monogr 2014; 63: 88-104
Year: 2014


Severity of OSA and Depression
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019


Proposed MID in FACIT and VAS scores for individuals attending COVID-19 rehabilitation.
Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2021



Severity biomarkers once infected
Source: Virtual Congress 2020 – Epidemiology
Year: 2020


Are ACQ scores a useful measure of severity in obese patients?
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013


Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021



The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Assessment of cognitive functions in stable COPD patients using PGI Memory Scale and to analyze for their correlation with patients‘ characteristics and BODE index
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


2 days at the sea-side! Effects on anxiety and depression scores, Health Locus of Control (HLOC) and Patient’s Global Impression of Change (PGIC) in COPD patients.
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018

Impact of symptoms of anxiety and depression on COPD Assessment Test scores
Source: Eur Respir J 2014; 43: 898-900
Year: 2014


Vitamin D and Bronchiectasis Severity Index (BSI): A correlation
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018


The Severe Asthma Questionnaire (SAQ) - minimal clinically important difference and sensitivity to change
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



The PROGRESS Study - Operationalization of Disease Severity and Prediction ofOutcome using the SOFA Score
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018


Use of Asthma Control Questionnaire (ACQ) Score to predict future risk of asthma exacerbation
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010


Reliability and validity of the visual analog scale (VAS) based symptom status index (SSI) in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 671s
Year: 2005

Effects of nintedanib in patients with IPF: subgroup analysis by Charlson Comorbidity Index (CCI)
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020